Other treatments proposed for enhancing MICA expression include sodium butyrate, matrix metalloproteinase inhibitor III, and phenylarsine oxide, all of which were recently shown, in multiple myeloma cell lines, to enhance MICA expression and increase cytotoxicity [38]. Here, MICA is linked to plasma cell myeloma.